defects was not compatible with life, and the ultimate cause of death in this case was likely pulmonary congestion with edema.
Isolation and antimicrobial susceptibilities of bacterial pathogens from bovine pneumonia: 1994-2002
Ronald D. Welsh, 1 Laura B. Dye, 1 Mark E. Payton, 3 Anthony W. Confer 2 Abstract. Between 1994 and 2002, a total of 390 (46.3%) Mannheimia haemolytica, 292 (34.7%) Pasteurella multocida, and 160 (19.0%) Histophilus somni were isolated at the Oklahoma Animal Disease Diagnostic Laboratory from lungs from 6-18-month-old beef cattle with pneumonia. The ratio of M. haemolytica isolations to P. multocida isolations decreased from 3.1 in 1994 to 0.8 in 2000 while increasing to 1.5 in 2002. Mannheimia haemolytica isolations significantly (P Ͻ 0.05) decreased from 62.5% in 1994 to between 30.6% and 50.4% in [1998] [1999] [2000] [2001] [2002] . Pasteurella multocida isolations significantly (P Ͻ 0.05) increased from 20.0% in 1994 to between 28.6% and 47.4% in [1998] [1999] [2000] [2001] [2002] . Histophilus somni isolations were Ͻ19% except in 1998 (40.8%) and 1999 (23%). Antimicrobial susceptibilities for M. haemolytica significantly declined for erythromycin (P ϭ 0.0001), florfenicol (P ϭ 0.0004), spectinomycin (P ϭ 0.0001), and tilmicosin (P ϭ 0.03). For P. multocida, antimicrobial susceptibilities significantly declined for erythromycin (P ϭ 0.0001), florfenicol (P ϭ 0.004), spectinomycin (P ϭ 0.03), sulfachloropyridizine (P ϭ 0.028), tetracycline (P ϭ 0.017), tilmicosin (P ϭ 0.0001), and trimethoprim/sulfamethoxazole (P ϭ 0.0003). Antimicrobial susceptibilities for H. somni were variable for spectinomycin and sulfachloropyridizine, whereas susceptibilities to other antibiotics remained consistently high.
Bovine respiratory disease (BRD) is the most economically important disease among beef cattle and is second only to gastrointestinal disease as a cause of disease and losses in dairy calves. Estimates of financial losses to the US cattle industry approach $1 billion per year. 14 Bovine respiratory disease is associated with stressful conditions, such as commingling and shipment of cattle, coupled with viral and bacterial infections. 30 The result of these conditions is often acute, severe bacterial pneumonia that can result in death, transient illness that may resolve after appropriate treatment, or progression to chronic pneumonia. 18 Poor feed conversion, reduced weight grains, and increased costs due to treatment accompany BRD. 14 Three bacteria are frequently associated with pneumonia seen in BRD. 3, 7, 18, 30 These are Mannheimia haemolytica (formerly Pasteurella haemolytica), Pasteurella multocida, and Histophilus somni (formerly Haemophilus somnus). Mannheimia haemolytica has traditionally been the most frequently isolated bacterium from cases of acute fibrinous pleuropneumonia seen in transported beef cattle. 30 In one study of isolations of bacteria from beef cattle pneumonia, 71.1% were M. haemolytica, 21.1% were P. multocida, and 7.8% were H. somnus. 29 Pasteurella multocida, however, is more frequently associated with fibrinopurulent bronchopneumonia in dairy calves. 7 All 3 organisms can be associated with bacterial pneumonia in both beef and dairy cattle. 3, 7, 18 Vaccines are available for each of these bacteria; however, their efficacy is less than ideal. 8, 20 Vaccination against the 3 respiratory bacterial pathogens has often been shown to reduce disease and improve production; however, vaccine-induced protection against bacterial pneumonia is never absolute. 14 A review of published literature on field trials using bovine respiratory vaccines concluded that efficacy could be demonstrated with M. haemolytica vaccines in approximately one half of the trials. 20 Traditionally, cattle producers have used vaccination for bacterial pathogens much less than vaccination for viral pathogens because of comparative lesser efficacy. A 1999 study by the United States Department of Agriculture's National Animal Health Monitoring System found that only 27.5% of feedlot operators vaccinated against Pasteurella spp. and 33.8% vaccinated against H. somni. 19 Therefore, antimicrobial therapy is extensively used to aid in prevention and for treatment of BRD. 4, 9, 10 A commonly used practice today to aid in prevention of BRD in high-risk feedlot cattle is metaphylaxis, wherein cattle are injected with an antimicrobial agent, usually tetracycline or tilmicosin, at the time of processing in a feedlot. 4, 9, 26, 31 For treatment of BRD, most veterinarians recommend aggressive antimicrobial therapy usually using one or combinations of tilmicosin, florfenicol, ceftiofur, or an enrofloxacin.
Effective use of antimicrobial agents for control and treatment of bovine bacterial pneumonia necessitates periodic evaluation of percentages of isolation of M. haemolytica, P. multocida, and H. somni from cases of pneumonia. In addition, analysis of trends in resistance and susceptibility to newer antibiotics help the veterinarian and the animal health industry keep abreast of potential antibiotic efficacy. Since their introduction beginning in the late 1980s-1990s, tilmicosin, florfenicol, ceftiofur, and enrofloxacin have been extensively used in the beef cattle industry; therefore, it is imperative that trends in antibiotic susceptibilities be reviewed for trends toward antibiotic resistance.
The purpose of this study was to review the percentage of isolations and the antibiotic susceptibilities of M. haemolytica, P. multocida, and H. somni from lungs from cases of bovine pneumonia submitted to a diagnostic laboratory between 1994 and 2002.
Samples of lung tissue or swabs of lung tissue obtained at necropsy from beef cattle 6-18 months of age were submitted to the Oklahoma Animal Disease Diagnostic Laboratory (OADDL), Stillwater, OK. On arrival, samples from lung tissue were obtained aseptically. Swabs submitted by the referring veterinarian or those obtained in the laboratory were streaked onto 5% sheep blood agar a according to standard procedures. 22 Blood agar plates were incubated in a 5% CO 2 incubator at 37 C for 18 hours. Bacterial isolates were identified by standard protocols. 22 To determine if there was a difference among the 3 bacteria over years, a 9 ϫ 3 contingency table and chi-square analysis were done with year as one factor and percentage bacteria isolated as another. b, 21 To determine if significant trends occurred for each bacterium over time, logistic regression analyses were done. b, 21 Antimicrobial susceptibilities were performed by modified Kirby-Bauer methods on Mueller-Hinton agar a with 5% bovine serum c added. 22 Procedures and susceptibility interpretations were standardized according to the published criteria by the National Committee for Clinical Laboratory Standards. 27 The zone diameters in the intermediate category were considered to be nonsusceptible. To determine if significant trends occurred for antimicrobial susceptibilities over time, logistic regression analyses were done for each antimicrobial agent and each bacterium. 21 A total of 842 isolates were examined and consisted of 390 (46.3%) M. haemolytica, 292 (34.7%) P. multocida, and 160 (19.0%) H. somni (Table 1) . Year-toyear variation occurred in the percentage of isolation of each bacterium (Table 1; Fig. 1a) . Pasteurella multocida was the most frequently isolated bacterial pathogen in 2000, and H. somni was the most frequently isolated bacterial pathogen in 1998. Chi-square analysis demonstrated highly significant differences among the bacterial isolations over years ( 2 ϭ 46.01, df ϭ 16, P Ͻ 0.0001). There was a significant trend for the percentage of isolation of M. haemolytica to decrease (slope ϭ Ϫ0.077, P ϭ 0.006), whereas the percentages of isolation of P. multocida significantly increased (slope ϭ 0.087, P ϭ 0.004). No significant trend in H. somni isolation was found (slope ϭ Ϫ0.0014, P ϭ 0.969). The ratio of M. haemolytica isolations to P. multocida isolations decreased from 3.1 in 1994 to 0.8 in 2000 while increasing to 1.5 in 2002 (Fig. 1b) . No specific trends were noted for the ratios for M. hae- 
molytica/H. somni or for P. multocida/H. somni (data not shown).
Mannheimia haemolytica antimicrobial susceptibilities were highly variable for ampicillin (range 42-82%) and tetracycline (range 23-74%) ( Table 2 ). In contrast, percent susceptibilities remained stable for ceftiofur (96-100%), cephalothin (96-98%), enrofloxacin (89-98%), sulfachloropyridizine (87-94%), and trimethoprim/sulfamethoxazole (90-99%). Susceptibilities significantly declined for erythromycin (slope ϭ Ϫ0.407, P ϭ 0.0001), florfenicol (slope ϭ Ϫ0.398, P Ͻ 0.0004), spectinomycin (slope ϭ Ϫ0.108, P ϭ 0.0001), and tilmicosin (slope ϭ Ϫ0.034, P ϭ 0.03).
Antimicrobial susceptibilities for P. multocida were highly variable for ampicillin (range 76-100%) ( Table  3 ). In contrast, percent susceptibilities remained stable for ceftiofur (96-100%), cephalothin (96-100%), and enrofloxacin (96-100%). Susceptibilities significantly declined for erythromycin (slope ϭ Ϫ0.047, P ϭ 0.0001), florfenicol (slope ϭ Ϫ0.286, P ϭ 0.004), spectinomycin (slope ϭ Ϫ0.059, P ϭ 0.03), sulfachloropyridizine (slope ϭ Ϫ0.088, P ϭ 0.028), tetracycline (slope ϭ Ϫ0.067, P ϭ 0.017), tilmicosin (slope ϭ Ϫ0.163, P ϭ 0.0001), and trimethoprim/sulfamethoxazole (slope ϭ Ϫ0.174, P ϭ 0.0003).
Antimicrobial susceptibilities for H. somni were variable for spectinomycin (range 65-86%) and sulfachloropyridizine (59-86%) ( Table 4 ). Susceptibilities to other antibiotics, however, remained consistently high (87-100%). There were no significant trends in antibiotic susceptibilities. In the classical study of beef cattle pneumonia, Pasteurella spp. were isolated from 62% of infected tracheas and pneumonic lungs from feedlot cattle dying of shipping fever. 16 Differentiation between M. haemolytica (then P. haemolytica) and P. multocida was not done. In this study, bacterial identification criteria used were those published for P. haemolytica before formation of the genus Mannheimia. 5, 23 Isolates were separated as A or T biotypes on the basis of biochemical profiles, and only those in the A biotype were reported because T biotypes are classified as Pasteurella trehalosi. Attempts to separate M. haemolytica from Mannheimia glucosida (formerly P. haemolytica serotype 11) were not done. 5 Mannheimia glucosida is rarely isolated from or associated with disease in cattle. 5 Others have found M. haemolytica to be the most frequently isolated bacterium from the respiratory tract of cattle with shipping fever. 12, 29 In contrast, P. multocida was isolated more frequently than M. haemolytica from either the nasal cavity or from bronchoalveolar lavages from feedlot cattle in 2 previous studies. 1,2 A review of isolation data from the OADDL records from 1982, 1986, 1989, and 1992 indicated that M. haemolytica was isolated from Ͼ60% of the bovine pneumonic lungs with M. haemolytica/P. multocida ratios ranging from 2.3-3.6 (data not shown). Findings from this study demonstrated a trend toward a reduced percentage of isolation of M. haemolytica and an increased percentage of isolation of P. multocida during an 8-year period. The cause of these findings is not known. Bacterial isolation procedures did not change during this period, and isolations were randomly received with never more than 2 separate isolates from the same contributor being processed on the same day. Therefore, it must be hypothesized that the observed shift in bacterial prevalence indicates an increased prevalence and perhaps importance of P. multocida in shipping fever pneumonia. In support of a heretofore under-recognized importance of P. multocida in shipping fever, in transported beef cattle low antibody titers to P. multocida on entry to the feedlot were associated with reduced net profit to the owners. 13 The causes of this trend toward reduced prevalence of M. haemolytica and increased prevalence of P. multocida could be related to changes in virulence among these bacterial pathogens, efficacies of currently available antimicrobial agents, changes in the way sick cattle are identified and treated, development of bacterial resistance to numerous antimicrobials-as described above, increased use of mass medication programs, or availability of newer more efficacious M. haemolytica vaccines with P. multocida vaccines remaining primarily as bacterins. 9 For example, between 1994 and 1998, 2 new antibiotics (enrofloxacin and florfenicol) became available and could have markedly affected the prevalence of these bacterial pathogens. Unfortunately, treatment records or other epidemiological data were not available for evaluation of the cases reported herein.
The Kirby-Bauer method is a traditional in vitro test of bacterial susceptibility or resistance to antimicrobial agents that uses a disk containing a standardized concentration of an antimicrobial agent. 22 Bacteria grow or fail to grow surrounding the disk, thus results are usually interpreted as resistance or susceptibility of the bacteria to certain antimicrobials. Minimal inhibitory concentrations (MICs) of antimicrobial agents are considered to correlate better with potential therapeutic outcome. 6 Although the Kirby-Bauer method may not be as clinically relevant as determining MICs of antimicrobial agents, the assay, as used in this study, is useful in determining trends in bacterial resistance and susceptibility.
In a previous study of antimicrobial susceptibilities of M. haemolytica, P. multocida, and H. somni isolated from BRD between 1988 and 1992, frequent resistance of M. haemolytica and P. multocida to ampicillin, erythromycin, tetracycline, and sulfamethazine was seen. 28 Ceftiofur, marketed originally in 1988, demonstrated consistent activity against the respiratory pathogens, whereas substantial ''variation in year-toyear susceptibility. . . to tilmicosin. . . was observed.'' 27 In this study, percent susceptibilities of M. haemolytica and P. multocida remained reasonably stable for ceftiofur, cephalothin, and enrofloxacin, whereas susceptibilities to erythromycin, florfenicol, spectinomycin, and tilmicosin declined significantly for both bacteria. It is intriguing that based on the results of the present and past studies, susceptibilities of bovine respiratory pathogens to ceftiofur have remained high since 1988, whereas susceptibilities of these bacteria to other commonly used antibiotics, such as erythromycin, florfenicol, and tilmicosin, have declined.
Tilmicosin, florfenicol, enrofloxacin, tetracyclines, and ceftiofur have in recent years been used substantially for treatment and prevention of bovine respiratory disease. 6, 9, 10, 11, 15, 17, 24 Use of these antibiotics in cattle has been shown to reduce the number of M. haemolytica in the nasal secretions or nasopharynx, reduce onset of respiratory disease, and reduce experimentally induced respiratory disease when given at the time of illness or on entry into a feedlot. 10, 11, 15, 17, 24, 26 Most studies have addressed performance data or concentrated on M. haemolytica. Therefore, although antibiotic treatment may decrease the nasal shedding or nasopharyngeal or pulmonary colonization with M. haemolytica, similar treatment may not effectively decrease P. multocida from the respiratory tract. It was postulated that P. multocida is an opportunistic pathogen that overgrows the lung previously damaged by other bacteria such as M. haemolytica. 3 Review of clinical data from feedlot cattle that died of M. haemolytica-and P. multocida-associated pneumonias could demonstrate a pattern of disease that is different for the 2 organisms. In fact, P. multocida is usually associated with a subacute to chronic bronchopneumonia, whereas M. haemolytica is associated with a more acute to subacute fibrinous pleuropneumonia. 18 Therefore, examination of feedlot treatment and production records from the cases reported herein could indicate different patterns of pneumonia for M. haemolytica and P. multocida that would be similar to that previously shown, wherein H. somni was associated with pneumonia later in the feeding period than was M. haemolytica. 23, 25 Finally, multiple factors may influence the outcome of production or clinical responses of cattle to treatment with antimicrobials in the field. The presence of other bovine pathogens such as the gram-positive Arcanobacterium pyogenes and cell wall-deficient Mycoplasma spp. may bias the outcome of antimicrobial treatment and metaphylaxis in either a positive or negative direction depending on the presence of those pathogens and their responses to the antimicrobials used.
